Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Has reproduction · 90
A genome-wide association analysis identifies 16 novel susceptibility loci for carpal tunnel syndrome.
PMID 30833571 · PMC6399342 · Nature communications · 2019 · 6 claims · 8 setups
A GWAS of 12,312 CTS cases and 389,344 controls in UK Biobank identifies 16 novel genome-wide significant susceptibility loci for CTS
-
Full-text index only
Genetic evidence supporting obesity as a risk factor for lung squamous cell carcinoma and the identification of MFAP1 as a shared genetic target.
PMID 41820721 · PMC13096280 · Discover oncology · 2026 · 8 claims · 8 setups
BMI and LUSC show a significant positive genome-wide genetic correlation, robust to constrained-intercept sensitivity analysis and replicated by GNOVA.
-
Full-text index only
Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traits.
PMID 41826324 · PMC13139607 · Nature communications · 2026 · 8 claims · 8 setups
T1D GWAS heritability is enriched in accessible chromatin of brain-resident cells, most notably microglia, across neurodevelopment into adulthood
-
Full-text index only
Multi-ancestry GWAS of age-related hearing loss identifies 140 loci and key cellular mechanisms.
PMID 41723152 · PMC13172361 · Nature communications · 2026 · 8 claims · 8 setups
A multi-ancestry GWAS meta-analysis of 456,613 cases and 1,053,834 controls identifies 140 independent loci associated with ARHL, including 44 novel signals.
-
Full-text index only
A causal glycerophospholipid-IL-18R1-CD9 axis connects lipid metabolism and T-cell activation in atopic dermatitis.
PMID 42061907 · PMC13132603 · Briefings in bioinformatics · 2026 · 7 claims · 8 setups
1-palmitoyl-2-arachidonoyl-GPC (PA-GPC) is a protective metabolite against AD that acts primarily by downregulating IL-18R1